Showing results (91-100 of 123) with videos related to
Sort By:
Pageof 13
Annals of Surgery|March 28, 2014
Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04Marcia M Russell, Patricia A Ganz, Samia Lopa, et al.Cancer Medicine|September 24, 2021
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinomaSamer S AlMasri, Mazen S Zenati, Annissa Desilva, et al.Annals of Surgical Oncology|November 24, 2020
Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case-Control Matched AnalysisAsmita Chopra, Jacob C Hodges, Adam Olson, et al.Annals of Surgical Oncology|November 29, 2017
Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM)Mashaal Dhir, Mazen S Zenati, Heather L Jones, et al.Plos Biology|August 18, 2004
The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesisDavid G Ransom, Nathan Bahary, Knut Niss, et al.The Journal of Liquid Biopsy|July 3, 2026
Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumorsMuhammad Anees, Patrick L Wagner, Ashten Omstead, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic CancerMitesh J Borad, Shantan G Reddy, Nathan Bahary, et al.Clinical Epigenetics|January 7, 2022
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysisChaoyuan Kuang, Yongseok Park, Ryan C Augustin, et al.Gastroenterology|March 6, 2019
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as BiomarkersAatur D Singhi, Ben George, Joel R Greenbowe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2016
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine TumorsAatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, et al.Pageof 13